Deniz Uysal Appointed as Hematology Business Unit Manager at GSK

Deniz Uysal has embarked on an exciting new chapter as Hematology Business Unit Manager at GSK, bringing nearly two decades of leadership experience across the pharmaceutical and healthcare industries. Recognized for driving commercial excellence, strategic growth, product launches, and portfolio optimization, Deniz has consistently delivered impactful results across hematology, oncology, immunology, and specialty care markets.

Prior to joining GSK, Deniz held several senior leadership roles at Eli Lilly and Company, including Senior Sales & Marketing Lead, Oncology, Senior Marketing Manager – Specialty & Omnichannel Engagement, and Marketing Manager across Immunology, Dermatology, and Specialty portfolios. Earlier in his career, he spent more than seven years at Novartis Oncology, where he successfully led hematology and oncology portfolios, launched innovative therapies, managed multi-million-dollar business units, and contributed to regional and global strategic initiatives. His professional journey also includes leadership positions at Pierre Fabre and Colgate-Palmolive, strengthening his expertise across healthcare and consumer sectors.

Deniz holds an MBA with High Honors from Yeditepe University and a Bachelor of Science in Molecular Biology & Genetics with High Honors from Boğaziçi University, where he graduated among the top-ranked students of his class. His strong blend of scientific knowledge, commercial leadership, strategic vision, and patient-focused innovation continues to position him as a respected leader within the global healthcare industry.